1. 1 Jaffe ES, Harris NL, Vardiman JM, Campo E, Arber DA: Hematopathology. St. Louis, Elsevier, pp.991-999, 2011
2. 2 Shenkier TN, Blay JY, O'Neill BP, Poortmans P, Thiel E, et al.: Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23:2233-2239, 2005
3. 3 Kluin PM, Deckert M: Primary DLBCL of the CNS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.240-241, 2008
4. 4 Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, et al.: Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time ? Brain Tumor Pathol 28:145-149, 2011
5. 5 Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, et al.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282, 2004